Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €27.90 | - | - |
| Insulet Corp. | 14 | 0 | 1 | 0 | €153.05 | €215.54 | 40.828% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €127.20 | €147.62 | 16.050% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €15.63 | €28.17 | 80.216% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.60 | €24.04 | 6.381% |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €22.80 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.14 | - | - |
| Codexis Inc. | 4 | 2 | 0 | 0 | €2.48 | €8.35 | 236.738% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €29.60 | €38.99 | 31.718% |
| Radnet Inc. | 7 | 3 | 1 | 0 | €45.40 | €50.90 | 12.108% |
| Glycomimetics Inc. | 5 | 0 | 1 | 0 | €1.53 | €7.35 | 381.126% |
| Cara Therapeutics Inc. | 8 | 1 | 2 | 0 | €0.64 | €4.63 | 625.596% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €69.00 | €79.43 | 15.115% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| Akebia Therapeutics Inc. | 8 | 3 | 2 | 1 | €1.25 | €3.60 | 188.389% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.67 | - | - |
| Affimed N.V. | 8 | 6 | 3 | 0 | €0.55 | €6.54 | 1083.165% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €127.00 | €150.00 | 18.110% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €74.50 | - | - |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €13.30 | - | - |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €2.19 | €12.27 | 460.438% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €127.08 | €133.66 | 5.178% |
| Faes Farma S.A. | 1 | 0 | 1 | 0 | €3.39 | €6.00 | 77.253% |